Treating Opioid Dependence With Buprenorphine Implants Proves To Be A Success

Posted on 10/16/2010 by meg

Research on the effects of the medication buprenorphine has demonstrated that it decreases opioid use when it is implanted under the skin. What exactly is an opioid? An opioid is more commonly known as heroin or prescription pain medications, such as oxycodone, hydrocodone, morphine, oxymorphone, fentanyl etc.

On the other hand, buprenorphine is a semi-synthetic opioid that is used to treat opioid addiction and to control moderate pain in non-opioid tolerant individuals. It is comparable to methadone treatment; though it is much more convenient as it does not require daily dispensing at a facility. Buprenorphine itself can be used recreationally, however in an effort to prevent injection of the drug, the Suboxone formulation includes naloxone, which precipitates opiate withdrawal and blocks any opiate effect.

Many studies have already supported the treatment of opioid addiction with buprenorphine; however, addicts often have difficulty keeping up with treatment as the medication is typically placed under the tongue to dissolve. As a result, when treatment isn’t followed accurately, it leaves room for cravings and withdrawal symptoms to creep in, which increases the likelihood that relapse may occur.
“To address these problems with adherence and nonmedical use, an implantable formulation of buprenorphine was developed that delivers a constant and low level of buprenorphine.”
Between the period of April 2007 and June 2008, Walter Ling, M.D., of the University of California, Los Angeles, and fellow researchers studied the effects of buprenorphine implants for treatment of opioid dependence at 18 different locations in the United States.

Of the addicts aged 18 to 65 years of age, diagnosed with opioid dependence, studied, 108 had buprenorphine implants while 55 had placebo implants. Four implants were placed under the skin on the inside of the non-dominant arm. Those with the real implants received gradual doses of 80 mg of buprenorphine.

In addition, all patients in the study were provided with standardized individual drug counseling. Opioid use was verified by urine samples. At the 6 month mark, all implants were removed.
“During the course of the study, the buprenorphine implant group had significantly more urine samples negative for illicit opioids during weeks 1 through 16. Patients with buprenorphine implants had an average percentage of urine samples that tested negative for illicit opioids of 40.4 percent and a median (midpoint) of 40.7 percent; those in the placebo group had an average of 28.3 percent and a median of 20.8 percent.”
Additionally, there were 65.7% of the patients that received treatment with buprenorphine who remained in the study for the full 24 weeks, whereas only 30.9% of those that received a placebo drug persevered for the duration of the study.

Consequently, the study concluded that 30.9% of patients in the placebo group had been unsuccessful in their treatment, whereas none of those that received buprenorphine failed their treatment. Furthermore, researchers claim that:

"Those who received buprenorphine implants also had fewer clinician-rated and patient-rated withdrawal symptoms, had lower patient ratings of craving, and experienced a greater change on clinician global ratings of severity of opioid dependence and on the clinician global ratings of improvement than those who received placebo implants".

Hence, this type of treatment for opioid use could prove to be very successful for many addicts once results have been replicated time and time again.

Implanting Medication to Treat Opioid Dependence Appears Beneficial in Decreasing Opioid Usage
Buprenorphine

© www.understandingaddictions.com

No Response to "Treating Opioid Dependence With Buprenorphine Implants Proves To Be A Success"

Leave A Reply

Labels

(+)-naloxone 6-acetylmorphine (6AM) Addiction Adenovirus Adolescence Adrenaline Aftershave Airplaning Alcohol Alcohol Poisoning Alcoholic Alcoholism Amphetamine Anaplasticity Anterior Cingulate Cortex Antibodies Anxiety Appetite Assault Attention Bath Salts Battery Acid Beer Belfast Benefits Benzoylmethylecgonine Bergen Facebook Addiction Scale Binge Drinking Biochemical Biological Clock Body Language Bone Fracture Bones Bonsai Grow Boot Camp Brain Brain Damage Break-Up British Columbia Bum Rushing Buprenorphine California Dreaming Canada Cancer Casino Cathinones Centers for Disease Control and Prevention China Choking Game Cigarette Circadian Rhythm Cirrhosis Citric Acid Cloud Nine Cocaine Cocaine Vaccine Cognitive Behavioral Therapy Common Cold Compulsivity Constitutional Right Content-Control Software Counselor Crack Craving Cues Death Decision-Making Demerol Dentist Dependence Dependency Depression Dilaudid Dopamine Dr. Drew Drain Cleaner Drug E-Cigarette Electric Shock Electronic Cigarette Emotion Employment Programs Engrams Exceptional Access Program (EAP) Facebook Facebook Addiction Failure Fainting Game Family Finances Flat Liner fMRI France Funky Chicken Gamblers Anonymous Gambling Genes Glutamate Government Grey Matter Hapten Harm Reduction Harvey Wallbanger Health Health Care Heart Attack Heart Disease Heroin Hillbilly Heroin HIV/AIDS Homelessness Hospitalization Human Rights Hunger Hurricane Charlie Hydrocodone Hydromorphone Hygiene Hypothalamus Illicit Drug Use Immune System Immune-Addiction Response Immunopharmacotherapy Implant Impulse Control Disorders Injection Injuries Instinct Internet Addiction Internet Gambling Intervention Ivory Wave Jay Leno Knockout Game Lantern Fuel Liver Long Term Depression Love Ludomania MADD Medial Prefrontal Cortex Medication Memories Memory Memory Traces Meperidine Mephedrone Mesolimbic Reward Pathway Methadone Methamphetamine Methylenedioxypyrovalerone (MDPV) Methylone Mid-Brain Money Montreal Morphine Motivation Mouthwash mRNA Muscle Control Naloxone Naltrexone Narcotic Negative Consequences Neural Pathway Nicotine Nicotine Gum Nicotine Patch Noradrenalin Norepinephrine Obsessive-Compulsive Online Gambling Ontario Disability Support Program (ODSP) Ontario Drug Benefit (ODB) Ontario Works (OW) Opiate Opioid Oral Hygiene Orbitofrontal Cortex Osteoporosis Ottawa Overdose Oxycodone Oxycontin Oxyneo Pain Pain Management Painkiller Paint Thinner Pass-out Game Pathological Computer Use Pathological Gambling Percocet Placebo Poker Pop Pre-frontal Cortex Prefrontal Cortex Prescription Drugs Propoxyphene Psychoactive Purple Dragon Rats Recovery Red Dove Rehab Rejection Relapse Relationships Research Research Validity Reward Reward and Punishment Risky Sexual Behavior RNA Safe Injection Site Salt Scarface Sensory Perception Serotonin Sex Addiction Shame Sleep/Wake Cycle Sleeper Hold Slot Machines Smoking Smoking-Cessation SNDRI Sobriety Social Assistance Social Media Social Security Soda Soda Addiction Sodium Sodium Ion Channel Space Monkey Speech Star Dust Striatum Subutex Successful Treatment Supreme Court of Canada Synapse Teenagers Tobacco Toll-Like receptor 4 (TLR4) Tooth Decay Tooth Enamel Tooth Erosion Treatment Trillium Drug Program Urine Sample Vaccine Vancouver Vanilla Sky Vaporize Vicodin Virus Vivitrol Welfare Wet Program White Lightning White Matter Wine Withdrawal

Health Blogs - Blog Rankings rdirectory.net